Current treatments for osteoarthritis in contemplating all knee (OAK) are poor. They provide symptom relief only and necessarily restore articular cartilage.

This really only excerpt from a presentation sign in American College of Rheumatology meeting an ultrasound-guided procedure using autologous mesenchymal stem cells, growth factors, m fat matrix (GMSCL).

The searching hypothesis was: autologous stem cells from bone marrow poor credit stimulated to grow cartilage if given...

• A proper scaffold
• Autologous restoration stimulating factors
• Limited weight-bearing

Our patient profile built in the following...

• 24 patients
• 36-64 years not in age
• 16 men; 6 women
• BMI: 21-36. 1
• Kellgren-Lawrence intricacy:
o 6 grade 2
o 10 higher education degree 3
o 6 grade 4

In mash, patients were given next instructions...

• No NSAIDS (oral and topical) nearly any month prior and 4 weeks post
• No fish oil primarily month prior and 4 weeks post
• May continue deterring baby aspirin
• No intraarticular injections regardless of the sort 1 month prior or during 12 months follow up.

Our procedure can be regarded as analogous to "Preparing which is a Garden"

• Sixty cc's marrow trimmed down posterior iliac crest (5 cc's peel from the lime cell concentrate~ 6 million stem cells)- "seeds"
• Sixty cc's peripheral blood for coming of platelet -rich plasma (5 cc's)- "fertilizer"
• Fifteen cc's fat from their own home abdomen or flank- "soil"

Ultrasound follow fenestration was performed entirely patients.

• Purpose: receive acute inflammatory response
• Joint capsule sites
- rotator cuff line
- adductor tubercle
- medial patellar facet

Regional treatment of fenestrated areas and joint was immediately after direct ultrasound-guided instillation of your respective...

• Stem cells
• Platelet-rich plasma
• Subcutaneous fat
• Limescale chloride/thrombin

Post-procedure, patients were given next instructions...

• Non-weight-bearing for two main weeks
• Limited weight-bearing with support that unloads affected compartment for 4-6 weeks

A summary of our results is usually as follows...

Data Available

• 11 Will be afflicted with at 6 months
• 10 Will be afflicted with at 12 months

Treatment failures

• Four patients
• Defined as patients with no clinical improvement after three or more months

Two other "failures"

• Yourself died of an less relevant illness
• One person lived far too away to come back

Five attitudes haven't hit the some month mark

WOMAC

? 6 Months= -19. 9

SD=17. 92

SEM= 5. 67

? 12 Months= -7. 9

SD= 9. 97

SEM= 3. 15

Patient VAS Pain

? 6 Months=-33. 7

SD= 12. 71

SEM= 5. 57

? 12 Months= -25. 2

SD= 27. 94

SEM= 8. 20

Patient Overall Assessment

? 6 Months= -33. 0

SD= 27. 13

SEM= 8. 05

? 12 Months= -33. 1

SD= 21. 04

SEM= 6. 35

Patient 50 Hallux Walk Pain

? 6 Months= -26. 3

SD= 15. 54

SEM= have a look at. 91

? 12 Months= -16. 7

SD= 12. 05

SEM= have a look at. 01

Physician Global Assessment

? 6 Months= -51. 2

SD= twenty-one. 60

SEM= 6. 83

? 12 Months= -53. 0

SD= 27. 15

SEM= 8. 54

Placebo electricity needs? Probably not...

Example of Celebrex vs placebo that can OA trials

Mean composite WOMAC health (pain, stiffness, physical function) equals -5. 7 (-7. 5 to be able to -3. 9)

[Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.Mayo Clin Proc 1999;74: 1095-1105; Zhao SZ, McMillen JI, Markenson JA, Dedhiya SD, Zhao WW, Osterhaus JT, et al.Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib. Pharmacotherapy 1999;19: 1269-1278].

Ultrasound period of patello-femoral cartilage concentration at 7 standardized points

• Calf flexed to 90 degrees
• Precisely the same sites matched for accuracy
• Five measurements each point for reproducibility
• High and low dropped fantastic three middle averaged

Ultrasound rank of patello-femoral cartilage thick at 7 standardized points

• Mean improvement from baseline to a year (11 pts) - 0. have a look at mm
• Mean improvement in baseline to 12 session (10 pts) - 0. 8 mm

Conclusion

While regarded as uncontrolled study, GMSCL demonstrates some promise to counter OAK. Further study is recommended

.

arrow
arrow
    全站熱搜
    創作者介紹
    創作者 knee 的頭像
    knee

    Arthritis In Knee|Osteoarthritis Knee|Knee Joint Pain

    knee 發表在 痞客邦 留言(0) 人氣()